Primary data · sourced from public filings·700+ listed companies · India-first·
Open screener
ἀλήθεια · aletheiaAncient Greek for truth — literally “un-forgetting”: the act of revealing reality, not merely stating it
← All posts
Sector Thesis·4 min read·Week 3

Pharma Tech Bridge Rounds: When to Cross, When to Wait

Bridge rounds in Indian pharma tech solve a timing problem: Series A takes 12-18 months, runway ends in 8. Convertible notes work when you have traction data. SAFEs fail here because equity investors want audited numbers.

ByAmit Tyagi·Fitoor Capital
Aletheia Insights · Weekly

Get 1 unfair insight every week from India's startup ecosystem.

Read by serious founders and investors. No fluff.

Blog Pass

Continue reading with Blog Pass

This piece is part of the Aletheia archive. This week’s drops are free — unlock every sector thesis, deal-flow breakdown and disclosure note with a Blog Pass.

₹999/mo·₹5,000/yrSave 58%
Get Blog Pass →

Amit Tyagi

Founder, AletheiaAI & GP, Fitoor Capital

Veteran of India's startup ecosystem. Writing about fundraising, investor psychology, and what it takes to build fundable startups in India.

Run a fundability check

India's only MRE-backed platform for founders and investors. Analyse your deck, find investors, and validate your raise strategy.

#pharma-tech#bridge-rounds#seed-to-series-a#convertible-notes

Don’t miss the next one

One insight every week. No fluff.

Aletheia Insights · Weekly

One contrarian insight. Every week. No generic startup advice.

Join founders and investors building with better information.

Pharma Tech Bridge Rounds: When to Cross, When to Wait · Aletheia Insights